Literature DB >> 22898351

Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.

Frank Benedix1, Frank Meyer, Rainer Kube, Siegfried Kropf, Doerthe Kuester, Hans Lippert, Albert Roessner, Sabine Krüger.   

Abstract

There is a growing amount of data supporting the concept that cancers originating from the proximal and distal colon are distinct clinicopathological entities. The incidence of MSI and BRAF mutation is strongly associated with right sided tumor location, whereas there are conflicting results for KRAS mutation rates. However, to date, no data exist whether and to what extent defined colonic subsites influence MSI status, KRAS and BRAF mutation rates. We selected primary colon cancer from 171 patients operated on at our institution between 2007 and 2010. BRAF, KRAS mutation rates and microsatellite instability were determined and correlated with clinicopathological features and tumor location. MSI-h cancers were significantly associated with poor histological grade but a lower rate of distant metastases. KRAS-mutated tumors were linked to lower T-stage and better differentiation. Colon carcinomas with BRAF mutation were significantly associated with distant metastatic spread and poor histological grade. Furthermore, we found that MSI-h status, KRAS and BRAF mutation rates varied remarkably among the colonic subsites irrespective of right- and left-sided origin, respectively. The results of the current study provide further evidence that a simple classification into right- and left-sided colon carcinoma does not represent the complexity of this tumor entity.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898351     DOI: 10.1016/j.prp.2012.07.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  16 in total

1.  Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

Authors:  Julien Taieb; Karine Le Malicot; Qian Shi; Frédérique Penault-Llorca; Olivier Bouché; Josep Tabernero; Enrico Mini; Richard M Goldberg; Gunnar Folprecht; Jean Luc Van Laethem; Daniel J Sargent; Steven R Alberts; Jean Francois Emile; Pierre Laurent Puig; Frank A Sinicrope
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

2.  The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.

Authors:  John M Creasy; Eran Sadot; Bas Groot Koerkamp; Joanne F Chou; Mithat Gonen; Nancy E Kemeny; Leonard B Saltz; Vinod P Balachandran; T Peter Kingham; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-11-27       Impact factor: 5.344

3.  Impact of Primary Tumor Location on Survival After Curative Resection in Patients with Colon Cancer: A Meta-Analysis of Propensity Score-Matching Studies.

Authors:  Mitsuru Ishizuka; Takayuki Shimizu; Norisuke Shibuya; Kazutoshi Takagi; Hiroyuki Hachiya; Yusuke Nishi; Kotaro Suda; Taku Aoki; Keiichi Kubota
Journal:  Oncologist       Date:  2020-10-21

4.  A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.

Authors:  Yan Zhang; Junli Ma; Sai Zhang; Ganlu Deng; Xiaoling Wu; Jingxuan He; Haiping Pei; Hong Shen; Shan Zeng
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

Review 5.  Metabolite and Microbiome Interplay in Cancer Immunotherapy.

Authors:  Caroline H Johnson; Mary E Spilker; Laura Goetz; Scott N Peterson; Gary Siuzdak
Journal:  Cancer Res       Date:  2016-10-11       Impact factor: 12.701

Review 6.  Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.

Authors:  Petros Christakis Papagiorgis
Journal:  Tumour Biol       Date:  2016-02-03

7.  Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.

Authors:  Jiefeng Zhao; Jinfeng Zhu; Rui Sun; Chao Huang; Rongfa Yuan; Zhengming Zhu
Journal:  BMC Cancer       Date:  2021-05-06       Impact factor: 4.430

Review 8.  The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.

Authors:  Gholamreza Safaee Ardekani; Seyed Mehdi Jafarnejad; Larry Tan; Ardavan Saeedi; Gang Li
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer.

Authors:  Per Jess; Iben Onsberg Hansen; Michael Gamborg; Tine Jess
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

10.  Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.

Authors:  M K H Maus; D L Hanna; C L Stephens; S H Astrow; D Yang; P P Grimminger; F Loupakis; J H Hsiang; G Zeger; T Wakatsuki; A Barzi; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2014-12-23       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.